Fasting mimicking diet reduces anti-OX40/anti PD-L1 and anti-PD-1/anti-CTLA-4 cardiovascular side effects in preclinical melanoma models

被引：0
|
作者：
Quagliariello, Vincenzo
Cortellino, Salvatore
Delfanti, Gloria
Di Mauro, Annabella
Tatangelo, Fabiana
Spagnolo, Vanessa
Visco, Euplio
Casorati, Giulia
Chiodoni, Claudia
Della Bona, Paolo
Blazevits, Olga
Ascierto, Paolo Antonio
Maurea, Nicola
Longo, Valter
机构：
[1] IRCCS Fdn G Pascale, Naples, Italy
[2] IRCCS CROB, Rionero In Vulture, Italy
[3] IRCCS S Raffaele Sci Inst, Milan, Italy
[4] Ist Nazl Tumori IRCCS Fdn G Pascale, Pathol Unit, Naples, Italy
[5] Natl Canc Inst Naples, Naples, Italy
[6] IFOM, Milan, Italy
[7] San Raffaele Inst, Milan, Italy
[8] Fdn IRCCS Isttuto Nazl Tumori, Milan, Italy
[9] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy
[10] Ist Nazl Studio & Cura Tumori Fdn G Pascale IRCCS, Div Cardiol, Naples, Italy
[11] IFOM FIRC Inst Mol Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12029
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center
    Afzal, Muhammad Z.
    Shirai, Keisuke
    MELANOMA RESEARCH, 2018, 28 (04) : 341 - 347
  • [32] Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
    Campbell, Katie M.
    Amouzgar, Meelad
    Pfeiffer, Shannon M.
    Howes, Timothy R.
    Medina, Egmidio
    Travers, Michael
    Steiner, Gabriela
    Weber, Jeffrey S.
    Wolchok, Jedd D.
    Larkin, James
    Hodi, F. Stephen
    Boffo, Silvia
    Salvador, Lisa
    Tenney, Daniel
    Tang, Tracy
    Thompson, Marshall A.
    Spencer, Christine N.
    Wells, Daniel K.
    Ribas, Antoni
    CANCER CELL, 2023, 41 (04) : 791 - +
  • [33] Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
    Afzal, Muhammad Zubair
    Mercado, Rima R.
    Shirai, Keisuke
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [34] Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis
    Wang, Bin
    Qin, Lei
    Ren, Mei
    Sun, Hao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) : 260 - 270
  • [35] The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
    Lihu Gu
    Parikshit Asutosh Khadaroo
    Hui Su
    Liya Kong
    Liangliang Chen
    Xianfa Wang
    Xinlong Li
    Hepan Zhu
    Xin Zhong
    Junhai Pan
    Manman Chen
    BMC Cancer, 19
  • [36] The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
    Gu, Lihu
    Khadaroo, Parikshit Asutosh
    Su, Hui
    Kong, Liya
    Chen, Liangliang
    Wang, Xianfa
    Li, Xinlong
    Zhu, Hepan
    Zhong, Xin
    Pan, Junhai
    Chen, Manman
    BMC CANCER, 2019, 19 (1)
  • [37] Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy
    Holmes, Zachary
    Courtney, Ashling
    Hiong, Alison
    BMJ CASE REPORTS, 2022, 15 (08)
  • [38] Pneumonitis with anti-PD-1/PD-L1 therapy
    Naidoo, J.
    Cunningham, J.
    Woo, K. M.
    Hellmann, M. D.
    Postow, M. A.
    Drilon, A. E.
    Chaft, J. E.
    Lesokhin, A. M.
    Segal, N. H.
    Callahan, M. K.
    Rudin, C. M.
    Iyriboz, T.
    Wolchok, J. D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S103 - S103
  • [39] SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer
    Patel, Sandip P.
    Guadarrama, Elizabeth
    Chae, Young Kwang
    Dennis, Michael J.
    Powers, Benjamin C.
    Liao, Chih-Yi
    Ferri, William A.
    George, Thomas J.
    Sharon, Elad
    Ryan, Christopher W.
    Othus, Megan
    Lopez, Gabby
    Blanke, Charles D.
    Kurzrock, Razelle
    CANCER, 2024, 130 (17) : 2918 - 2927
  • [40] Combination Therapy with Anti-CTLA-4 and Anti-PD-1 Leads to Distinct Immunologic Changes In Vivo
    Das, Rituparna
    Verma, Rakesh
    Sznol, Mario
    Boddupalli, Chandra Sekhar
    Gettinger, Scott N.
    Kluger, Harriet
    Callahan, Margaret
    Wolchok, Jedd D.
    Halaban, Ruth
    Dhodapkar, Madhav V.
    Dhodapkar, Kavita M.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (03): : 950 - 959
12345